Literature DB >> 12200534

GM-CSF therapy in pulmonary alveolar proteinosis.

M G de Vega, A Sánchez-Palencia, A Ramírez, S Cervera, J Aneiros.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2002        PMID： 12200534      PMCID： PMC1746416          DOI： 10.1136/thorax.57.9.837

Source DB:  PubMed          Journal:  Thorax        ISSN： 0040-6376            Impact factor:   9.139


× No keyword cloud information.
  4 in total

1.  Anti-GM-CSF antibodies in paediatric pulmonary alveolar proteinosis.

Authors:  P Latzin; M Tredano; Y Wüst; J de Blic; T Nicolai; B Bewig; F Stanzel; D Köhler; M Bahuau; M Griese
Journal:  Thorax       Date:  2005-01       Impact factor: 9.139

Review 2.  Pathogenesis of pneumonia and acute lung injury.

Authors:  Matthew E Long; Rama K Mallampalli; Jeffrey C Horowitz
Journal:  Clin Sci (Lond)       Date:  2022-05-27       Impact factor: 6.876

Review 3.  Congenital Pulmonary Alveolar Proteinosis: From Birth to Ten-years of Age.

Authors:  Sandra Alavuk Kundović; Ljiljana Popović
Journal:  Indian J Pediatr       Date:  2017-05-17       Impact factor: 1.967

Review 4.  Metabolic Functions of the Lung, Disorders and Associated Pathologies.

Authors:  Alcibey Alvarado; Isabel Arce
Journal:  J Clin Med Res       Date:  2016-08-30
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.